These templates are for use in preparation for the data evaluation record (DER) for the indicated study.
View the test guidelines for the endocrine disruptor screening program (Series 890).
You may need a PDF reader to view some of the files on this page. See EPA’s About PDF page to learn more.- Amphibian Metamorphosis (PDF)(25 pp, 318 K, September 2011, Guideline: 890.1100)
- Androgen Receptor Binding (Rat Prostate) (PDF)(14 pp, 286 K, October 2011, Guideline: 890.1150)
- Aromatase (Human Recombinant) (PDF)(12 pp, 196 K, July 2011, Guideline: 890.1200)
- Estrogen Receptor Binding (PDF)(15 pp, 300 K, October 2011, Guideline: 890.1250)
- Estrogen Receptor Transcriptional Activation (Human Cell Line HeLa-9903) (PDF)(10 pp, 166 K, August 2011, Guideline: 890.1300)
- Fish Short-Term Reproduction (PDF)(31 pp, 523 K, October 2011, Guideline: 890.1350)
- Hershberger (Rat) (PDF)(13 pp, 292 K, October 2011, Guideline: 890.1400)
- Female Pubertal (Rat) (PDF)(12 pp, 181 K, August 2011, Guideline: 890.1450)
- Male Pubertal (Rat) (PDF)(12 pp, 182 K, August 2011, Guideline: 890.1500)
- Steroidogenesis (Human Cell Line – H295R) (PDF)(9 pp, 193 K, July 2011, Guideline: 890.1550)
- Uterotrophic (Rat) (PDF)(13 pp, 217 K, September 2011, Guideline: 890.1600)